← Leaderboards
Y Joseph Woo
University Of Pennsylvania
$12,952,260
Attributed
$12,952,260
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,952,260 · 3
By mechanism
R01$12,289,950 · 2
K08$662,310 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Alison Marie Pouch$4,262,160
- Robert C Gorman$19,903,116
- Thomas P Cappola$16,895,234
- Michael I. Kotlikoff$12,824,600
- Mariusz A Wasik$8,531,349
Others in their field
Top investigators on “Heart”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$118,439,174
- Deborah Nickerson · University Of Washington$86,844,068
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
HeartVentricularCardiacAnimal ModelBiomechanicsAnimalsEngineeringRepairedMechanicsIn VivoAngiogenesisHeart FailureOperative Surgical ProceduresMyocardialTissue EngineeringDesignVentricular RemodelingInnovationMyocardial IschemiaPropertyTranslationsPhysiologicalPre-ClinicalCharacteristics
Grant awards (24)
Biomechanical Optimization of Mitral Valve Repair Operations$3,153,055
R01 · FY2025 · HL · contact PI
Biomechanical Optimization of Cardiac Valve Repair Operations$689,743
R01 · FY2023 · HL · contact PI
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery$621,547
R01 · FY2023 · HL · contact PI
Biomechanical Optimization of Cardiac Valve Repair Operations$689,743
R01 · FY2022 · HL · contact PI
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery$625,369
R01 · FY2022 · HL · contact PI
Biomechanical Optimization of Cardiac Valve Repair Operations$689,743
R01 · FY2021 · HL · contact PI
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery$644,149
R01 · FY2021 · HL · contact PI
Biomechanical Optimization of Cardiac Valve Repair Operations$693,768
R01 · FY2020 · HL · contact PI
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery$620,196
R01 · FY2020 · HL · contact PI
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING$382,038
R01 · FY2018 · HL · contact PI
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING$381,325
R01 · FY2017 · HL · contact PI
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING$380,659
R01 · FY2016 · HL · contact PI
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING$374,337
R01 · FY2015 · HL · contact PI
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING$379,465
R01 · FY2014 · HL · contact PI
Angiogenic tissue engineering to limit post-infarction ventricular remodeling$389,813
R01 · FY2012 · HL · contact PI
Angiogenic tissue engineering to limit post-infarction ventricular remodeling$393,750
R01 · FY2011 · HL · contact PI
Angiogenic tissue engineering to limit post-infarction ventricular remodeling$393,750
R01 · FY2010 · HL · contact PI
Angiogenic tissue engineering to limit post-infarction ventricular remodeling$393,750
R01 · FY2009 · HL · contact PI
Angiogenic tissue engineering to limit post-infarction ventricular remodeling$393,750
R01 · FY2008 · HL · contact PI
Angiogenesis and Cardiac Growth as Heart Failure Therapy$132,462
K08 · FY2008 · HL · contact PI
Angiogenesis and Cardiac Growth as Heart Failure Therapy$132,462
K08 · FY2007 · HL · contact PI
Angiogenesis and Cardiac Growth as Heart Failure Therapy$132,462
K08 · FY2006 · HL · contact PI
Angiogenesis and Cardiac Growth as Heart Failure Therapy$132,462
K08 · FY2005 · HL
Angiogenesis and Cardiac Growth as Heart Failure Therapy$132,462
K08 · FY2004 · HL